+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Preclinical CRO Market Size, Share & Trends Analysis Report By Service (Toxicology Testing, Bioanalysis & DMPK Studies), By End Use (Biopharmaceutical Companies, Government & Academic Institutes), And Segment Forecasts, 2021 - 2028

  • ID: 5450194
  • Report
  • September 2021
  • Region: Global
  • 240 pages
  • Grand View Research

FEATURED COMPANIES

  • Envigo Corporation
  • Eurofins Scientific
  • ICON Plc.
  • Medpace, Inc.
  • MPI research
  • PRA Health Sciences, Inc
The global preclinical CRO market size is expected to reach USD 8.4 billion by 2028, expanding at a CAGR of 8.1%, according to a new report by the publisher The market is expected to show lucrative growth due to increasing R&D expenditure and rising outsourcing trends. The increasing volume of new drugs entering the preclinical phase is also anticipated to boost the market over the forecast period.

The market is undergoing a series of mergers and acquisitions resulting in improvement in full-service capabilities and international reach of larger companies. For instance, in 2019, WuXi AppTec acquired Pharmapace. On the other hand, mid-sized and smaller contract research organizations are focusing on niche sectors and are providing a personalized approach to their sponsors. Various companies are focusing on research and development of new drugs and therefore are outsourcing these activities to launch efficient CRO services in the market. This, in turn, provides a positive atmosphere for joint ventures among market participants owing to the preference of sponsors to maximize their benefits.

The COVID-19 pandemic is ever increasing since the disease was first identified in China in December 2019. Until January 20, 2021, more than 96.7 million cases of COVID-19 were reported globally, with more than 2,068,303 deaths, across the globe. This pandemic has fast-tracked the development of vaccines and drug testing. There are currently more than 50 COVID-19 vaccine candidates in preclinical studies as well as trials.

North America held the highest revenue share of the global market in 2020. Huge investments in healthcare R&D coupled with well-developed healthcare infrastructure in the U.S. contributed to the market growth in North America. Asia Pacific is projected to expand with the fastest CAGR of 12.0% over the forecast period.

Preclinical CRO Market Report Highlights

  • The toxicology testing segment accounted for the largest share of more than 22% in 2020 due to its significance in Investigational New Drug (IND)-enabling studies
  • The government and academic institutes segment is anticipated to witness the fastest CAGR of 8.5% over the forecast period
  • This growth is credited to the rising government initiatives in the healthcare sector, especially in developing economies
  • North America dominated the market in 2020. Huge healthcare R&D expenditure is the major factor driving the regional market
  • Asia Pacific is projected to record the fastest CAGR of 12.0% over the forecast period
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Envigo Corporation
  • Eurofins Scientific
  • ICON Plc.
  • Medpace, Inc.
  • MPI research
  • PRA Health Sciences, Inc
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Service
1.1.2. End-use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1: Understanding the market dynamics
1.9.2. Objective 2: Understanding the market estimates and forecasts
1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
1.9.4. Objective 4: Understanding the key product and end-use scopes to conclude on the market size

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Preclinical CRO Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Surging number of drugs in preclinical phases
3.3.1.2. Economies of production and scale
3.3.1.3. Increasing R&D expenditure
3.3.2. Market Restraint Analysis
3.4.2.1. High labor cost
3.4.2.2. Stringent regulatory policies
3.3.3. Industry Challenges
3.3.3.1. Managing the relationships
3.4. Preclinical CRO: Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier Power
3.4.1.2. Buyer Power
3.4.1.3. Substitution Threat
3.4.1.4. Threat from new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political Landscape
3.4.2.2. Environmental Landscape
3.4.2.3. Social Landscape
3.4.2.4. Technology Landscape
3.4.2.5. Legal Landscape
3.4.3. Major Deals & Strategic Alliances Analysis

Chapter 4. Preclinical CRO Market: Segment Analysis, By Service, 2016 - 2028 (USD Million)
4.1. Definitions & Scope
4.2. Segment Dashboard
4.3 Service market share analysis, 2020 & 2028
4.4. Global Preclinical CRO Market, by service, 2016 to 2028
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
4.5.1. Bioanalysis and DMPK studies
4.5.1.1. In vitro ADME
4.5.1.2. In vivo PK
4.5.2. Toxicology Testing
4.5.2.1. GLP
4.5.2.2. Non-GLP
4.5.3. Compound Management
4.5.3.1. Process R&D
4.5.3.2. Custom Synthesis
4.5.3.2. Others
4.5.4. Chemistry
4.5.4.1. Medicinal Chemistry
4.5.4.2. Computation Chemistry
4.5.5. Safety Pharmacology
4.5.6. Others

Chapter 5. Preclinical CRO Market: Segment Analysis, By End-use, 2016 - 2028 (USD Million)
5.1. Definitions & Scope
5.2. End-use market share analysis, 2020 & 2028
5.3. Segment Dashboard
5.4. Global Preclinical CRO market, by end-use, 2016 to 2028
5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
5.5.1. Biopharmaceutical Companies
5.5.2. Government & Academic Institutes
5.5.3. Medical Device Companies

Chapter 6. Preclinical CRO Market: Regional Market Analysis, By Services, 2016 - 2028 (USD Million)
6.1. Definitions & Scope
6.2. Regional Market Share Analysis, 2020 & 2028
6.3. Regional Market Dashboard
6.4. Regional Market Snapshot
6.5. Regional Market Share, 2018
6.6. Market Size, & Forecasts, and Trend Analysis, 2016 to 2028:
6.7. North America
6.7.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
6.7.2. Market estimates and forecast, by Services, 2016 - 2028 (USD Million)
6.7.3. Market estimates and forecast, by End-use, 2016 - 2028 (USD Million)
6.7.4. U.S.
6.7.4.1. Market estimates and forecast, by Services, 2016 - 2028 (USD Million)
6.7.4.2. Market estimates and forecast, by End-use, 2016 - 2028 (USD Million)
6.7.5. Canada
6.7.5.1. Market estimates and forecast, by Services, 2016 - 2028 (USD Million)
6.7.5.2. Market estimates and forecast, by End-use, 2016 - 2028 (USD Million)
6.8. Europe
6.8.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
6.8.2. Market estimates and forecast, by Services, 2016 - 2028 (USD Million)
6.8.3. Market estimates and forecast, by End-use, 2016 - 2028 (USD Million)
6.8.4. Germany
6.8.4.1. Market estimates and forecast, by Services, 2016 - 2028 (USD Million)
6.8.4.2. Market estimates and forecast, by End-use, 2016 - 2028 (USD Million)
6.8.5. U.K.
6.8.5.1. Market estimates and forecast, by Services, 2016 - 2028 (USD Million)
6.8.5.2. Market estimates and forecast, by End-use, 2016 - 2028 (USD Million)
6.8.6. France
6.8.6.1. Market estimates and forecast, by Services, 2016 - 2028 (USD Million)
6.8.6.2. Market estimates and forecast, by End-use, 2016 - 2028 (USD Million)
6.8.7. Italy
6.8.7.1. Market estimates and forecast, by Services, 2016 - 2028 (USD Million)
6.8.7.2. Market estimates and forecast, by End-use, 2016 - 2028 (USD Million)
6.8.8. Spain
6.8.8.1. Market estimates and forecast, by Services, 2016 - 2028 (USD Million)
6.8.8.2. Market estimates and forecast, by End-use, 2016 - 2028 (USD Million)
6.9. Asia Pacific
6.9.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
6.9.2. Market estimates and forecast, by Services, 2016 - 2028 (USD Million)
6.9.3. Market estimates and forecast, by End-use, 2016 - 2028 (USD Million)
6.9.4. China
6.9.4.1. Market estimates and forecast, by Services, 2016 - 2028 (USD Million)
6.9.4.2. Market estimates and forecast, by End-use, 2016 - 2028 (USD Million)
6.9.5. Japan
6.9.5.1. Market estimates and forecast, by Services, 2016 - 2028 (USD Million)
6.9.5.2. Market estimates and forecast, by End-use, 2016 - 2028 (USD Million)
6.9.6. India
6.9.6.1. Market estimates and forecast, by Services, 2016 - 2028 (USD Million)
6.9.6.2. Market estimates and forecast, by End-use, 2016 - 2028 (USD Million)
6.9.7. Australia
6.9.7.1. Market estimates and forecast, by Services, 2016 - 2028 (USD Million)
6.9.7.2. Market estimates and forecast, by End-use, 2016 - 2028 (USD Million)
6.9.8. South Korea
6.9.8.1. Market estimates and forecast, by Services, 2016 - 2028 (USD Million)
6.9.8.2. Market estimates and forecast, by End-use, 2016 - 2028 (USD Million)
6.10. Latin America
6.10.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
6.10.2. Market estimates and forecast, by Services, 2016 - 2028 (USD Million)
6.10.3. Market estimates and forecast, by End-use, 2016 - 2028 (USD Million)
6.10.4. Brazil
6.10.4.1. Market estimates and forecast, by Services, 2016 - 2028 (USD Million)
6.10.4.2. Market estimates and forecast, by End-use, 2016 - 2028 (USD Million)
6.10.5. Mexico
6.10.5.1. Market estimates and forecast, by Services, 2016 - 2028 (USD Million)
6.10.5.2. Market estimates and forecast, by End-use, 2016 - 2028 (USD Million)
6.10.6. Argentina
6.10.6.1. Market estimates and forecast, by Services, 2016 - 2028 (USD Million)
6.10.6.2. Market estimates and forecast, by End-use, 2016 - 2028 (USD Million)
6.11. Middle East and Africa
6.11.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
6.11.2. Market estimates and forecast, by Services, 2016 - 2028 (USD Million)
6.11.3. Market estimates and forecast, by End-use, 2016 - 2028 (USD Million)
6.11.4. South Africa
6.11.4.1. Market estimates and forecast, by Services, 2016 - 2028 (USD Million)
6.11.4.2. Market estimates and forecast, by End-use, 2016 - 2028 (USD Million)
6.11.5. Saudi Arabia
6.11.5.1. Market estimates and forecast, by Services, 2016 - 2028 (USD Million)
6.11.5.2. Market estimates and forecast, by End-use, 2016 - 2028 (USD Million)

Chapter 7. Preclinical CRO Market - Competitive Analysis
7.1. Key companies profiled
7.1.1. Envigo Corporation
7.1.1.1. Company Overview
7.1.1.2. Financial Performance
7.1.1.3. Product Benchmarking
7.1.1.4. Strategic Initiatives
7.1.2. MPI research
7.1.2.1. Company Overview
7.1.2.2. Financial Performance
7.1.2.3. Product Benchmarking
7.1.2.4. Strategic Initiatives
7.1.3. Eurofins Scientific
7.1.3.1. Company Overview
7.1.3.2. Financial Performance
7.1.3.3. Product Benchmarking
7.1.3.4. Strategic Initiatives
7.1.4. PRA Health Sciences, Inc
7.1.4.1. Company Overview
7.1.4.2. Financial Performance
7.1.4.3. Product Benchmarking
7.1.4.4. Strategic Initiatives
7.1.5. Wuxi AppTec
7.1.5.1. Company Overview
7.1.5.2. Financial Performance
7.1.5.3. Product Benchmarking
7.1.5.4. Strategic Initiatives
7.1.6. Medpace, Inc.
7.1.6.1. Company Overview
7.1.6.2. Financial Performance
7.1.6.3. Product Benchmarking
7.1.6.4. Strategic Initiatives
7.1.7. Pharmaceutical Product Development (PPD), LLC
7.1.7.1. Company Overview
7.1.7.2. Financial Performance
7.1.7.3. Product Benchmarking
7.1.7.4. Strategic Initiatives
7.1.8. PARAXEL International Corporation
7.1.8.1. Company Overview
7.1.8.2. Financial Performance
7.1.8.3. Product Benchmarking
7.1.8.4. Strategic Initiatives
7.1.9. ICON Plc.
7.1.9.1. Company Overview
7.1.9.2. Financial Performance
7.1.9.3. Product Benchmarking
7.1.9.4. Strategic Initiatives
7.1.10. Laboratory Corporation of America, Inc.
7.1.10.1. Company Overview
7.1.10.2. Financial Performance
7.1.10.3. Product Benchmarking
7.1.10.4. Strategic Initiatives 

List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Preclinical CRO Market, By Region, 2016 - 2028 (USD Million)
Table 4 Global Preclinical CRO Market, By Services, 2016 - 2028 (USD Million)
Table 5 Global Preclinical CRO Market, By End-use, 2016 - 2028 (USD Million)
Table 6 North America Preclinical CRO Market, By Country, 2016 - 2028 (USD Million)
Table 7 North America Preclinical CRO Market, By Services, 2016 - 2028 (USD Million)
Table 8 North America Preclinical CRO Market, By End-use, 2016 - 2028 (USD Million)
Table 9 The U.S. Preclinical CRO Market, By Services, 2016 - 2028 (USD Million)
Table 10 The U.S. Preclinical CRO Market, By End-use, 2016 - 2028 (USD Million)
Table 11 Canada Preclinical CRO Market, By Services, 2016 - 2028 (USD Million)
Table 12 Canada Preclinical CRO Market, By End-use, 2016 - 2028 (USD Million)
Table 13 Europe Preclinical CRO Market, By Country, 2016 - 2028 (USD Million)
Table 14 Europe Preclinical CRO Market, By Services, 2016 - 2028 (USD Million)
Table 15 Europe Preclinical CRO Market, By End-use, 2016 - 2028 (USD Million)
Table 16 The U.K. Preclinical CRO Market, By Services, 2016 - 2028 (USD Million)
Table 17 The U.K. Preclinical CRO Market, By End-use, 2016 - 2028 (USD Million)
Table 18 Germany Preclinical CRO Market, By Services, 2016 - 2028 (USD Million)
Table 19 Germany Preclinical CRO Market, By End-use, 2016 - 2028 (USD Million)
Table 20 France Preclinical CRO Market, By Services, 2016 - 2028 (USD Million)
Table 21 France Preclinical CRO Market, By End-use, 2016 - 2028 (USD Million)
Table 22 Italy Preclinical CRO Market, By Services, 2016 - 2028 (USD Million)
Table 23 Italy Preclinical CRO Market, By End-use, 2016 - 2028 (USD Million)
Table 24 Spain Preclinical CRO Market, By Services, 2016 - 2028 (USD Million)
Table 25 Spain Preclinical CRO Market, By End-use, 2016 - 2028 (USD Million)
Table 26 Asia Pacific Preclinical CRO Market, By Services, 2016 - 2028 (USD Million)
Table 27 Asia Pacific Preclinical CRO Market, By End-use, 2016 - 2028 (USD Million)
Table 28 China Preclinical CRO Market, By Services, 2016 - 2028 (USD Million)
Table 29 China Preclinical CRO Market, By End-use, 2016 - 2028 (USD Million)
Table 30 Japan Preclinical CRO Market, By Services, 2016 - 2028 (USD Million)
Table 31 Japan Preclinical CRO Market, By End-use, 2016 - 2028 (USD Million)
Table 32 India Preclinical CRO Market, By Services, 2016 - 2028 (USD Million)
Table 33 India Preclinical CRO Market, By End-use, 2016 - 2028 (USD Million)
Table 34 Australia Preclinical CRO Market, By Services, 2016 - 2028 (USD Million)
Table 35 Australia Preclinical CRO Market, By End-use, 2016 - 2028 (USD Million)
Table 36 South Korea Preclinical CRO Market, By Services, 2016 - 2028 (USD Million)
Table 37 South Korea Preclinical CRO Market, By End-use, 2016 - 2028 (USD Million)
Table 38 Latin America Preclinical CRO Market, By Services, 2016 - 2028 (USD Million)
Table 39 Latin America Preclinical CRO Market, By End-use, 2016 - 2028 (USD Million)
Table 40 Brazil Preclinical CRO Market, By Services, 2016 - 2028 (USD Million)
Table 41 Brazil Preclinical CRO Market, By End-use, 2016 - 2028 (USD Million)
Table 42 Mexico Preclinical CRO Market, By Services, 2016 - 2028 (USD Million)
Table 43 Mexico Preclinical CRO Market, By End-use, 2016 - 2028 (USD Million)
Table 44 Argentina Preclinical CRO Market, By Services, 2016 - 2028 (USD Million)
Table 45 Argentina Preclinical CRO Market, By End-use, 2016 - 2028 (USD Million)
Table 46 Middle East & Africa Preclinical CRO Market, By Services, 2016 - 2028 (USD Million)
Table 47 Middle East & Africa Preclinical CRO Market, By End-use, 2016 - 2028 (USD Million)
Table 48 South Africa Preclinical CRO Market, By Services, 2016 - 2028 (USD Million)
Table 49 South Africa Preclinical CRO Market, By End-use, 2016 - 2028 (USD Million)
Table 50 Saudi Arabia Preclinical CRO Market, By Services, 2016 - 2028 (USD Million)
Table 51 Saudi Arabia Preclinical CRO Market, By End-use, 2016 - 2028 (USD Million)

List of Figures
Figure. 1 Market research process
Figure. 2 Data triangulation techniques
Figure. 3 Primary research pattern
Figure. 4 Market research approaches
Figure. 5 Value-chain-based sizing & forecasting
Figure. 6 QFD modeling for market share assessment
Figure. 7 Market formulation & validation
Figure. 8 Preclinical CRO Market: Market snapshot
Figure. 9 Preclinical CRO Market: Market segmentation
Figure. 10 Preclinical CRO Market Strategy framework
Figure. 11 Parent market outlook
Figure. 12 Related/ancillary market outlook
Figure. 13 Preclinical CRO Market driver impact
Figure. 14 Preclinical CRO Market restraint impact
Figure. 15 Preclinical CRO Market porter’s five forces analysis
Figure. 16 Preclinical CRO Market PESTEL analysis
Figure. 17 Preclinical CRO Market segment dashboard
Figure. 18 Preclinical CRO Market: Services movement Analysis
Figure. 19 Bioanalysis and DMPK studies market estimates and forecast, 2016 - 2028 (USD Million)
Figure. 20 Toxicology testing market estimates and forecast, 2016 - 2028 (USD Million)
Figure. 21 Others market estimates and forecast, 2016 - 2028 (USD Million)
Figure. 22 Preclinical CRO Market segment dashboard
Figure. 23 Preclinical CRO Market: End-use Movement Analysis
Figure. 24 Biopharmaceutical companies market estimates and forecast, 2016 - 2028 (USD Million)
Figure. 25 Government and academic institutes market estimates and forecast, 2016 - 2028 (USD Million)
Figure. 26 Medical device companies market estimates and forecast, 2016 - 2028 (USD Million)
Figure. 27 Global Preclinical CRO Market: Regional movement analysis
Figure. 28 Global Preclinical CRO Market: Regional Outlook and key takeaways
Figure. 29 Global market share, by region
Figure. 30 North America market estimates and forecast, 2016 - 2028 (USD Million)
Figure. 31 The U.S. market estimates and forecast, 2016 - 2028 (USD Million)
Figure. 32 Canada market estimates and forecast, 2016 - 2028 (USD Million)
Figure. 33 Europe market estimates and forecast, 2016 - 2028 (USD Million)
Figure. 34 The U.K. market estimates and forecast, 2016 - 2028 (USD Million)
Figure. 35 Germany market estimates and forecast, 2016 - 2028 (USD Million)
Figure. 36 France market estimates and forecast, 2016 - 2028 (USD Million)
Figure. 37 Italy market estimates and forecast, 2016 - 2028 (USD Million)
Figure. 38 Spain market estimates and forecast, 2016 - 2028 (USD Million)
Figure. 39 Asia Pacific market estimates and forecast, 2016 - 2028 (USD Million)
Figure. 40 China market estimates and forecast, 2016 - 2028 (USD Million)
Figure. 41 Japan market estimates and forecast, 2016 - 2028 (USD Million)
Figure. 42 India market estimates and forecast, 2016 - 2028 (USD Million)
Figure. 43 Australia market estimates and forecast, 2016 - 2028 (USD Million)
Figure. 44 South Korea market estimates and forecast, 2016 - 2028 (USD Million)
Figure. 45 Latin America market estimates and forecast, 2016 - 2028 (USD Million)
Figure. 46 Brazil market estimates and forecast, 2016 - 2028 (USD Million)
Figure. 47 Mexico market estimates and forecast, 2016 - 2028 (USD Million)
Figure. 48 Argentina market estimates and forecast, 2016 - 2028 (USD Million)
Figure. 49 Middle East and Africa. market estimates and forecast, 2016 - 2028 (USD Million)
Figure. 50 South Africa market estimates and forecast, 2016 - 2028 (USD Million)
Figure. 51 Saudi Arabia market estimates and forecast, 2016 - 2028 (USD Million)
Note: Product cover images may vary from those shown
  • Envigo Corporation
  • MPI research
  • Eurofins Scientific
  • PRA Health Sciences, Inc
  • Wuxi AppTec
  • Medpace, Inc.
  • Pharmaceutical Product Development (PPD), LLC
  • PARAXEL International Corporation
  • ICON Plc.
  • Laboratory Corporation of America, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll